GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Clinical trials for GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Stomach cancer chemo study stopped early – too few volunteers
Disease control TerminatedThis study aimed to see if giving all chemotherapy before surgery (FLOT-TNT) was better than splitting it before and after surgery (FLOT-POP) for stomach or GEJ cancer. Only 3 people took part, and the study was stopped early. Because of this, no reliable conclusions can be drawn…
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 12:10 UTC
-
Experimental cancer pill trial halted early
Disease control TerminatedThis early-stage study tested an experimental pill called PRT7732 in people with advanced solid tumors that have a specific genetic mutation (SMARCA4). The main goals were to check safety, find the right dose, and see if the drug shrinks tumors. The study was terminated early, an…
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
Experimental stomach cancer combo trial halted after only 2 patients
Disease control TerminatedThis early-stage study tested a new drug called AUR103 combined with standard treatments (trastuzumab and chemotherapy) for people with advanced HER2-positive stomach or gastroesophageal junction cancer. The goal was to see if the combination was safe and effective. However, the …
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated May 13, 2026 16:01 UTC